OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
Jana Koch, Zina M. Uckeley, Patricio Doldan, et al.
The EMBO Journal (2021) Vol. 40, Iss. 16
Open Access | Times Cited: 292

Showing 26-50 of 292 citing articles:

Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
Judith M. White, Joshua T. Schiffer, Rachel Bender Ignacio, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 58

Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination
Thanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9376-9395
Closed Access | Times Cited: 57

Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection
Simon J. L. Petitjean, Wenzhang Chen, Melanie Koehler, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54

SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Scott B. Biering, Francielle Tramontini Gomes de Sousa, Laurentia V. Tjang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50

Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45

Choosing a cellular model to study SARS-CoV-2
Gabriel Augusto Pires de Souza, Marion Le Bideau, Céline Boschi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 43

Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2
Jasper Fuk‐Woo Chan, Bingjie Hu, Yue Chai, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 9, pp. 100743-100743
Open Access | Times Cited: 40

SARS-CoV-2 evolution influences GBP and IFITM sensitivity
Dejan Mesner, Ann‐Kathrin Reuschl, Matthew Whelan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 5
Open Access | Times Cited: 36

Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 34

Altered host protease determinants for SARS-CoV-2 Omicron
Jasper Fuk‐Woo Chan, Xiner Huang, Bingjie Hu, et al.
Science Advances (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 32

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Delphine Planas, Isabelle Staropoli, Vincent Michel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 32

Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1
Ilyas Khan, Sunan Li, Hongtao Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11

Single-molecule imaging reveals allosteric stimulation of SARS-CoV-2 spike receptor binding domain by host sialic acid
Marco A. Díaz-Salinas, Aastha Jain, Natasha D. Durham, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 9

Discovering natural products as potential inhibitors of SARS-CoV-2 spike proteins
Muhammad Alqaaf, Ahmad Kamal Nasution, Mohammad Bozlul Karim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Ritika Khatri, Gazala Siddqui, Srikanth Sadhu, et al.
Medical Microbiology and Immunology (2022) Vol. 212, Iss. 1, pp. 103-122
Open Access | Times Cited: 36

Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism
Romano Strobelt, Julia Adler, Nir Paran, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33

SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells
Rayhane Nchioua, Annika Schundner, Dorota Kmieć, et al.
Journal of Virology (2022) Vol. 96, Iss. 11
Open Access | Times Cited: 32

Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies
Marwah Karim, Sirle Saul, Luca Ghita, et al.
Antiviral Research (2022) Vol. 204, pp. 105367-105367
Open Access | Times Cited: 31

Insight into the role of clathrin‐mediated endocytosis inhibitors in SARS‐CoV‐2 infection
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Soumya Ghosh, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 30

IgG N-glycome changes during the course of severe COVID-19: An observational study
Tea Petrović, Amrita Vijay, Frano Vučković, et al.
EBioMedicine (2022) Vol. 81, pp. 104101-104101
Open Access | Times Cited: 29

Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development
Julie Bigay, Roger Le Grand, Frédéric Martinon, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29

SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase
Pinja Kettunen, Angelina Lesnikova, Noora Räsänen, et al.
Journal of Virology (2023) Vol. 97, Iss. 4
Open Access | Times Cited: 22

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22

Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides
Yue Hu, Yuanmei Zhu, Yanying Yu, et al.
Antiviral Research (2023) Vol. 212, pp. 105571-105571
Open Access | Times Cited: 18

Scroll to top